« Ind. Law - "More States Use GPS to Track Abusers" | Main | Environment - "Former coal lobbyist tapped for key enforcement role at IDEM" »
Saturday, May 09, 2009
Courts - Academic journal publisher Elsevier admits to putting out six fake Australian medical journals, paid for by big pharma
Ben Goldacre of The Guardian reports today:
A fascinating court case in Australia has been playing out around some people who had heart attacks after taking the Merck drug ÂVioxx. * * *For more, see this entry today from Slashdot.com, headed "More Fake Journals From Elsevier ."The first fun thing to emerge in the Australian case is email documentation showing staff at Merck made a "hit list" of doctors who were critical of the company, or of the drug. This list contained words such as "neutralise", "neutralised" and "discredit" next to the names of various doctors.
"We may need to seek them out and destroy them where they live," said one email, from a Merck employee. Staff are also alleged to have used other tactics, such as trying to interfere with academic appointments, and dropping hints about how funding to institutions might dry up. Institutions might think about whether they wish to receive money from a company like that in future. Worse still, is the revelation that Merck paid the publisher Elsevier to produce a publication.
The relationship between big pharma and publishers is perilous. Any industry with global revenues of $600bn can afford to buy quite a lot of adverts, and pharmaceutical companies also buy glossy expensive "reprints" of the trials it feels flattered by. As we noted in this column two months ago, there is evidence that all this money distorts editorial decisions.This time Elsevier Australia went the whole hog, giving Merck an entire publication which resembled an academic journal, although in fact it only contained reprinted articles, or summaries, of other articles. In issue 2, for example, nine of the 29 articles concerned Vioxx, and a dozen of the remainder were about another Merck drug, Fosamax. All of these articles presented positive conclusions. Some were bizarre: such as a review article containing just two references. * * *
Things have deteriorated since. It turns out that Elsevier put out six such journals, sponsored by industry. The Elsevier chief executive, Michael Hansen, has now admitted that they were made to look like journals, and lacked proper disclosure. "This was an unacceptable practice and we regret that it took place," he said.
Posted by Marcia Oddi on May 9, 2009 02:54 PM
Posted to Courts in general